Table 2.
Endpoints | Control group (n = 150) | Filter group (n = 155) | Risk difference (%) | 95 % CI |
---|---|---|---|---|
SIRS, sepsis, organ failure and mortality | ||||
SIRS | 54 | 39 | −11.3 | −21.8 to (−0.5)* |
Sepsis | 10 | 8 | −2.0 | −6.5 to 2.5 |
Circulatory failure | 35 | 32 | −2.5 | −11.8 to 6.7 |
ARDS | 14 | 7 | −3.5 | −9.0 to 1.9 |
Acute renal failure | 10 | 8 | −1.6 | −7.0 to 3.9 |
Acute liver failure | 6 | 2 | −2.3 | −5.3 to 0.6 |
Mortality | 15 | 7 | −5.8 | −11.5 to 0.1 |
Organ dysfunction | ||||
Cardiovascular dysfunction | 31 | 28 | −2.3 | −11.0 to 6.3 |
Hematologic dysfunction | 19 | 9 | −8.1 | −14.2 to (−0.2)* |
Hepatic dysfunction | 10 | 6 | −2.8 | −7.8 to 2.2 |
Neurologic dysfunction | 1 | 1 | 0.0 | −2.0 to 2.0 |
Renal dysfunction | 29 | 16 | −10.0 | −17.0 to (−3.0)* |
Respiratory dysfunction | 27 | 19 | −5.6 | −13.6 to 2.4 |
Table shows incidence of different complications in control and filter groups, risk differences and corresponding 95 % confidence interval (CI) according to Wald method
Calculation of a P value was statistically inappropriate in a subgroup analysis. Therefore, risk differences in incidence rates and their corresponding 95 % CI were determined. A 95 % CI on either side below zero indicated a statistically significant difference between both groups (*). SIRS, renal and hematologic dysfunction were significantly reduced in the filter group